Honduran authorities approved Gan & Lee Pharmaceuticals' (SHA:603087) insulin glargine injection for diabetes, according to a Monday filing with the Shanghai bourse.
The drug is said to have a hypoglycemic effect lasting 24 hours, the company said in its filing.